Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF – Get Free Report) shares reached a new 52-week low during trading on Thursday . The company traded as low as $20.50 and last traded at $20.50, with a volume of 270 shares changing hands. The stock had previously closed at $24.25.
Hikma Pharmaceuticals Stock Down 11.5%
The stock’s 50 day moving average is $23.45 and its 200-day moving average is $25.66. The company has a quick ratio of 0.72, a current ratio of 1.24 and a debt-to-equity ratio of 0.33.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Recommended Stories
- Five stocks we like better than Hikma Pharmaceuticals
- How to Calculate Options Profits
- Upwork’s Stock Soars on Q3 Blowout and a New AI Blueprint
- Top Stocks Investing in 5G Technology
- The Metals Market Is Heating Up—4 Stocks Poised to Shine
- Stock Sentiment Analysis: How it Works
- Tempus AI: Volatility Equates to Opportunity in AI Leader
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
